Home/Filings/4/0001213900-17-003339
4//SEC Filing

OptimizeRx Corp 4

Accession 0001213900-17-003339

$OPRXCIK 0001448431operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:04 PM ET

Size

5.3 KB

Accession

0001213900-17-003339

Insider Transaction Report

Form 4
Period: 2017-03-31
Hamilton Terrence
DirectorVice President
Transactions
  • Award

    Stock Option

    2017-03-31+200,000200,000 total
    Exercise: $0.82From: 2018-01-01Exp: 2022-03-31Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The Stock Options were issued based on performance criteria and only vest upon target revenue achieved in 2017.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001448431

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:04 PM ET
Size
5.3 KB